VASCULAR THERAPIES

vascular-therapies-logo

Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of patients requiring a vascular access to support hemodialysis. Our lead product candidate, containing sirolimus, has received orphan drug designations in the U.S. and E.U. for the dialysis vascular access indications. The company was founded in 2001 and headquartered in Cresskill, New Jersey.

#SimilarOrganizations #People #Financial #Website #More

VASCULAR THERAPIES

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2001-01-01

Address:
Cresskill, New Jersey, United States

Country:
United States

Website Url:
http://www.vasculartx.com

Total Employee:
1+

Status:
Active

Contact:
(201) 266-8310

Email Addresses:
[email protected]

Total Funding:
89.96 M USD

Technology used in webpage:
U.S. Server Location


Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

inovio-pharmaceuticals-logo

Inovio Pharmaceuticals

Inovio is a biotech company focusing on bringing to market DNA medicines for diseases associated with HPV, cancer, and infectious diseases.

pantheryx-logo

PanTheryx

PanTheryx is a nutrition and biotechnology company that utilizes the cellular and biomolecular processes of bovine colostrum.

renovacor-logo

Renovacor

Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.

Current Employees Featured

sriram-iyer_image

Sriram Iyer
Sriram Iyer Founder, Chief Scientific Officer & Board Member @ Vascular Therapies
Founder, Chief Scientific Officer & Board Member

john-mcdermott_image

John McDermott
John McDermott CEO @ Vascular Therapies
CEO
2019-01-01

Founder


sriram-iyer_image

Sriram Iyer

Investors List

cnf-investments_image

CNF Investments, LLC

CNF Investments, LLC investment in Private Equity Round - Vascular Therapies

savitr-capital_image

Savitr Capital

Savitr Capital investment in Venture Round - Vascular Therapies

Official Site Inspections

http://www.vasculartx.com

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 75.2.70.75
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Vascular Therapies"

Vascular Therapies | Improving Vascular Access

Vascular Therapies is improving vascular access by reducing surgical stenosis.See details»

About Vascular Therapies

Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogenâ„¢, an investigational sirolimus …See details»

Vascular Therapies - Crunchbase Company Profile & Funding

Vascular Therapies (VT) is a biopharmaceutical company committed to the development and commercialization of innovative new treatments to address major unmet clinical needs of …See details»

Vascular Therapies

Vascular Therapies is a privately held, biopharma company developing Sirogen, a proprietary sirolimus formulation for local, perivascular drug delivery. The goal of this therapeutic …See details»

Vascular Therapies - LinkedIn

Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. The company has developed Sirogenâ„¢,...See details»

Vascular Therapies Completes Enrollment in the ACCESS 2

Aug 5, 2024 · Vascular Therapies, Inc. is a privately‑held, biotechnology company that is developing Sirogen, a sirolimus drug formulation for local, perivascular drug delivery. The goal …See details»

Vascular Therapies Completes $25 Million Private Financing - PR …

Mar 29, 2022 · Vascular Therapies is a privately held, biopharma company developing Sirogenâ„¢, a proprietary sirolimus formulation for local, perivascular drug delivery. The goal of this …See details»

Vascular Therapies Completes Enrollment in the ACCESS Study, a …

Aug 19, 2019 · Vascular Therapies, Inc. ("VT") is a privately‑held, biotechnology company that has developed a proprietary sirolimus formulation for local, perivascular drug delivery. The …See details»

Vascular Therapies completes $25 million private financing

Mar 29, 2022 · Vascular Therapies is a privately held, biopharma company developing SirogenTM, a proprietary sirolimus formulation for local, perivascular drug delivery. The goal of …See details»

Vascular Therapies - Craft

Vascular Therapies is a biopharmaceutical company that specializes in the treatments for patients requiring an AV fistula for dialysis.See details»

News - Vascular Therapies

Vascular Therapies, Inc. is a privately‑held, biotechnology company that is developing Sirogen, a sirolimus drug formulation for local, perivascular drug delivery. The goal of this therapeutic …See details»

Vascular Therapies Announces Positive Preliminary Clinical Results …

CRESSKILL, N.J., Sept. 9, 2019 /PRNewswire/ -- Vascular Therapies, a clinical stage biotechnology company, is developing Sirogenâ„¢, a proprietary sirolimus formulation for …See details»

Vascular Therapies - Overview, News & Similar companies

Vascular Therapies contact info: Phone number: (201) 266-8310 Website: www.vasculartx.com What does Vascular Therapies do? Vascular Therapies, Inc., is a privately held, biopharma …See details»

News - Vascular Therapies

Vascular Therapies is a privately held, biopharma company developing Sirogen TM, a proprietary sirolimus formulation for local, perivascular drug delivery. The goal of this therapeutic …See details»

Vascular Therapies Completes Upsized $17.3 Million Private …

Jan 28, 2020 · Vascular Therapies, Inc., is a privately-held biopharma company developing Sirogen, a proprietary sirolimus formulation for local, perivascular drug delivery. The goal of …See details»

Vascular Therapies Completes $25 Million Private Financing

Mar 29, 2022 · Vascular Therapies is a privately held, biopharma company developing Sirogenâ„¢, a proprietary sirolimus formulation for local, perivascular drug delivery. The goal of this …See details»

Vascular Therapies Announces Clinical Results From Its Phase 3 ...

Apr 29, 2021 · CRESSKILL, N.J.-- ( BUSINESS WIRE )--Vascular Therapies, a privately held biotechnology company is developing Sirogenâ„¢, a proprietary sirolimus formulation for …See details»

ACCESS 2 Clinical Study | An AV Fistula Trial - Vascular Therapies

Switching from your catheter to an AV fistula? Getting an AV fistula is an important step in your treatment journey. AV fistulas are the best access choice for hemodialysis according to the …See details»

Vascular Therapies Announces Presentation of Phase 3 Clinical …

CRESSKILL, N.J., Nov. 4, 2021 /PRNewswire/ -- Vascular Therapies, a privately held biotechnology company is developing Sirogen â„¢, a proprietary sirolimus formulation for …See details»

Vascular Therapies Inc. | Cresskill NJ - Facebook

Vascular Therapies Inc., Cresskill, New Jersey. 20 likes. Vascular Therapies, Inc., a privately-held late-stage biopharmaceutical company, is developing...See details»

linkstock.net © 2022. All rights reserved